Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ute Berweiler"'
Autor:
Uwe Schlegel, Bettina Müller, Matthias Wenghoefer, Karlheinz Heuser, Knut Dietzmann, Nicole Glesmann, Martina Beck, Matthias Schmidt, Rolf Schröder, Sabine Diete, Andreas von Deimling, Rolf Fimmers, Svenja Mohr, Ute Berweiler, Wolfgang Roggendorf, Jürgen Kraus
Publikováno v:
Journal of Neuro-Oncology. 52:263-272
Glioblastoma multiforme (WHO grade IV; GBM) is the most common primary brain tumor with a median survival of less than one year despite multimodal treatment regimens. However, a small subgroup of GBM patients has a better clinical outcome, with a sma
Autor:
Andreas Krone, Ute Berweiler
Publikováno v:
Zeitschrift für medizinische Ethik. 40:15-21
Publikováno v:
Journal of Neuro-Oncology. 38:141-143
This paper describes the current techniques for intraventricular drug administration in patients with meningiosis. Advantages and disadvantages of different reservoir systems, the standard implantation procedure and more recently developed image-guid
Autor:
Bettina Müller, Matthias Schmidt, Karlheinz Heuser, Jürgen Kraus, Andreas von Deimling, Matthias Wenghoefer, Knut Dietzmann, Sabine Diete, G. Reifenberger, Ute Berweiler, Uwe Schlegel, Wolfgang Roggendorf
Publikováno v:
Journal of neurology. 247(6)
The overall prognosis for patients with glioblastoma multiforme is extremely poor. However, a small proportion of patients enjoy prolonged survival. This study investigated retrospectively the extent to which erroneous histopathological classificatio
Autor:
Falk Dittrich, James A. Miller, Anne Große-Wilde, Ute Berweiler, Qiao Yan, Michael Sendtner, Klaus V. Toyka, G. Ochs
Publikováno v:
Experimental neurology. 141(2)
Brain-derived neurotrophic factor (BDNF) is a potential drug for treatment of amyotrophic lateral sclerosis. Previous studies have demonstrated little or no penetration of the blood-brain barrier by BDNF, hence systemic application does not result in